Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1

NCT07528014 is registered in ClinicalTrials.gov with Salma Health, Inc. as lead sponsor.

NCT NCT07528014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07528014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Lead sponsor
Salma Health, Inc.
Phase
Observational
Overall status
Recruiting
Start date
March 25, 2026
Completion date
March 31, 2037
Enrollment
5,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depressed mood